Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

New Options for Antiplatelet Therapy

This program is designed to educate pharmacists on newly available antiplatelet therapies (prasugrel, ticagrelor, and vorpaxar). The program will cover the mechanism of action, dosing, contraindications, significant clinical trials, and clinical pearls of these therapies. Upon completion of this CPE program, participants should be able to differentiate between the new antiplatlet agents, identify contraindications for these medications, and list monitoring parameters for patients taking these therapies.



CE Hours


CE Units


Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists


Disclosure Policy
The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict.  The existence of relationships does not necessarily imply bias or lessen the value of the activity.  All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers.  The relevant commercial financial relationships or affiliations must have occured over the past 12 months.

Accreditation Council for Pharmacy Education
Southern Illinois University Edwardsville School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity.   Log in to CPE Monitor at to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.


Requirements for CE Credit

To receive CE credit, the participant must complete the entire course (be present for the entire live presentation, read the monograph in its entirety etc.), and complete the online pretest and post-test with a score greater than that specified for the course.   The participant must  also complete the online evaluation.
Continuing pharmacy education credit is reported to CPE Monitor once tall requirements for the activity are successfully completed.  


We would like to acknowledge the support and mentorship of Jennifer Rosselli, Pharm.D., Clinical Assistant Professor of Pharmacy Practice.  Southern Illinois university Edwardsville. 





  • Describe the importance of antiplatelet therapy in secondary prevention of cardiovascular disease
  • Differentiate between the new antiplatelet medications in terms of chemical class, mechanism of action, and dosing
  • Identify contraindications for the newly approved antiplatelet medications
  • List the monitoring parameters for patients on antiplatelet therapy


Breanna Wyman, Pharm.D. Candidate
Pharm.D. Candidate, Southern Illinois University Edwardsville

Brief Bio : Graduated from Indiana State University in 2011 with a Bachelor's in Chemistry

Cathryn McIntosh
Student Pharmacist, Southern Illinois University Edwardsville

Brief Bio : Cathryn is a fourth year student at the SIUE School of Pharmacy.
Disclosure : No disclosures noted

Activity Number


Release Date: Dec 10, 2014
Credit Expiration Date: Dec 10, 2017

CE Hours